Financial Performance - For the year ended December 31, 2023, the company reported a net loss of 2,251,116,withoperatingcostsof2,654,975 and interest income of 510,728[162].−Thecompanyhasidentifiedaratioof315,613,395, including 5,325,694fromtheIPOand287,701 in interest income [137]. - The total amount in the trust account reached 69,000,000aftertheunderwritersfullyexercisedtheirover−allotmentoption,resultinginanadditional9,000,000 [164]. - As of December 31, 2023, the company had withdrawn 129,288ofinterestearnedontheTrustAccounttopaytaxes[168].−AsofDecember31,2023,thecompanyhadcashof16,089 held outside the Trust Account for general working capital purposes [171]. - Cash used in operating activities for the year ended December 31, 2023, was 470,675,withchangesinoperatingassetsandliabilitiesproviding2,291,169 of cash [166]. Business Combination and Compliance - The company extended the time to complete its initial Business Combination from February 16, 2024, to May 16, 2024, by depositing 51,932intoitstrustaccount[175].−ThecompanyhasuntilNovember16,2024,toconsummateaBusinessCombination,withapotentialmandatoryliquidationifnotcompletedbythatdate[176].−Thecompanyenteredintoanon−bindingtermsheetwithCUBEBIOCo.,Ltd.foraproposedbusinesscombinationonMay2,2024[158].−ThecompanyreceivedanoticefromNasdaqonDecember13,2023,indicatingnon−compliancewiththe35,000,000 market value of listed securities requirement [139]. - The company regained compliance with the Nasdaq MVLS Rule on June 5, 2024, after maintaining a market value of 35,000,000orgreaterfortenconsecutivebusinessdays[141].DebtandFinancialObligations−Thecompanyissuedanon−interestbearing,unsecuredpromissorynoteof300,000 to the Sponsor, which can be converted into 75,000 shares of Common Stock upon consummation of a Business Combination [172]. - As of December 31, 2023, there was 52,877outstandingunderapromissorynotewithUHYAdvisors,with5,587 of interest accrued [173]. - The underwriters are entitled to a deferred fee of 0.30perunit,totaling2,070,000, payable only if the company completes a Business Combination [180]. - The company does not have any long-term debt or off-balance sheet financing arrangements as of December 31, 2023 [178][179]. - The company has no obligations or liabilities considered off-balance sheet arrangements as of December 31, 2023 [178]. Accounting and Regulatory Matters - The company does not believe that any recently issued accounting standards will have a material effect on its financial statements [188]. - The company extended the Combination Period twice in 2024, depositing $51,932 each time into its trust account [152].